Remote Specialty Sales Rep Cardiometabolic Rare Disease

Arrowhead Pharmaceuticals, Inc.; Meridian (MS); Remote; USD 160,000 - 180,000; Full time

Benefits offered by this job

Equity (RSUs)

Car allowance

Health, dental, vision, 401(k)

Job summary

Arrowhead Pharmaceuticals is seeking experienced Specialty Sales Representatives to launch and grow our cardiometabolic portfolio, including Plozasiran (siRNA targeting APOC3). You will drive prescriber activation, accelerate therapy adoption, and ensure sustained utilization in complex healthcare environments.

The role requires strategic territory planning, strong clinical acumen, and execution across IDNs and specialist networks, with travel up to 30% and remote engagement.

Qualifications

• Bachelor's degree or equivalent experience required.
• 5+ years of pharmaceutical sales experience.
• 3+ years in specialty, rare disease, or cardiovascular areas preferred.

Responsibilities

• Develop and execute data-driven territory business plans aligned to brand strategy and launch objectives.
• Analyze territory data (prescribing trends, account potential, access landscape) to identify growth opportunities and prioritize high-value targets.
• Manage territory budget including speaker programs and promotional initiatives.
• Deliver compliant, clinically accurate product education within approved labeling.
• Support patient identification and therapy initiation through provider engagement.

Skills

Territory planning

Clinical data communication

Relationship building

Commercial acumen

Resilience

Performance targets

Organizational skills

Education

Bachelor's degree or equivalent experience

Job description

Arrowhead Pharmaceuticals is seeking experienced Specialty Sales Representatives to launch and grow our cardiometabolic portfolio, including Plozasiran (siRNA targeting APOC3). You will drive prescriber activation, accelerate therapy adoption, and ensure sustained utilization in complex healthcare environments.

The role requires strategic territory planning, strong clinical acumen, and execution across IDNs and specialist networks, with travel up to 30% and remote engagement.